期刊
FEBS LETTERS
卷 583, 期 9, 页码 1409-1414出版社
WILEY
DOI: 10.1016/j.febslet.2009.04.011
关键词
BCL2L12; Ubiquitination; HSP70
资金
- National Natural Scientific Foundation of China [30700132, 30470442, 30330320]
- Shanghai Educational Development Foundation [2007CG02]
- Shanghai Leading Academic Discipline Project [B110]
- CNHLPP [2004BA711A19]
- Development of Science and Technology of Shanghai [ZR14011, 02DJ14002]
BCL2L12 has been found to be associated with favorable prognosis in breast cancer patients while correlated with tumorigenesis of glioblastoma and colon cancer. Here, we report that BCL2L12 and its transcript variant BCL2L12A are degraded through ubiquitin-proteasome system (UPS). Interestingly, the ubiquitinations and degradations of BCL2L12 and BCL2L12A are independent of the internal lysine residues but the first N-terminal residues. In addition, HSP70 was identified to interact with BCL2L12 and BCL2L12A and protected them from ubiquitinations and degradations in mammalian cells. In summary, HSP70 protects BCL2L12 and BCL2L12A from N-terminal ubiquitination-mediated proteasomal degradation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据